Salarius Pharmaceuticals (SLRX) Competitors

60 Degrees Pharmaceuticals (NASDAQ:SXTP) and Salarius Pharmaceuticals (NASDAQ:SLRX) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, valuation, risk, institutional ownership, dividends, analyst recommendations, community ranking and media sentiment.

Do analysts prefer SXTP or SLRX?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
60 Degrees Pharmaceuticals	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Salarius Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Do institutionals and insiders believe in SXTP or SLRX?

8.0% of 60 Degrees Pharmaceuticals shares are owned by institutional investors. Comparatively, 11.9% of Salarius Pharmaceuticals shares are owned by institutional investors. 10.3% of 60 Degrees Pharmaceuticals shares are owned by company insiders. Comparatively, 1.4% of Salarius Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Is SXTP or SLRX more profitable?

60 Degrees Pharmaceuticals' return on equity of 0.00% beat Salarius Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
60 Degrees Pharmaceuticals	N/A	N/A	-113.43%
Salarius Pharmaceuticals	N/A	-140.28%	-105.76%

Does the MarketBeat Community favor SXTP or SLRX?

Salarius Pharmaceuticals received 25 more outperform votes than 60 Degrees Pharmaceuticals when rated by MarketBeat users. Likewise, 54.17% of users gave Salarius Pharmaceuticals an outperform vote while only 5.00% of users gave 60 Degrees Pharmaceuticals an outperform vote.

Company	Underperform	Outperform
60 Degrees Pharmaceuticals	Outperform Votes 1 5.00%	Underperform Votes 19 95.00%
Salarius Pharmaceuticals	Outperform Votes 26 54.17%	Underperform Votes 22 45.83%

Does the media refer more to SXTP or SLRX?

In the previous week, 60 Degrees Pharmaceuticals had 1 more articles in the media than Salarius Pharmaceuticals. MarketBeat recorded 4 mentions for 60 Degrees Pharmaceuticals and 3 mentions for Salarius Pharmaceuticals. Salarius Pharmaceuticals' average media sentiment score of 0.96 beat 60 Degrees Pharmaceuticals' score of 0.22 indicating that Salarius Pharmaceuticals is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
60 Degrees Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Salarius Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has preferable valuation and earnings, SXTP or SLRX?

60 Degrees Pharmaceuticals has higher revenue and earnings than Salarius Pharmaceuticals. Salarius Pharmaceuticals is trading at a lower price-to-earnings ratio than 60 Degrees Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
60 Degrees Pharmaceuticals	$607.57K	6.21	-$3.77M	-$50.41	-0.05
Salarius Pharmaceuticals	N/A	N/A	-$12.54M	-$7.07	-0.10

Which has more risk and volatility, SXTP or SLRX?

60 Degrees Pharmaceuticals has a beta of 3.41, meaning that its stock price is 241% more volatile than the S&P 500. Comparatively, Salarius Pharmaceuticals has a beta of 0.6, meaning that its stock price is 40% less volatile than the S&P 500.

Summary

60 Degrees Pharmaceuticals and Salarius Pharmaceuticals tied by winning 7 of the 14 factors compared between the two stocks.